A benchtop bioreactor system developed at Hannover Medical School can produce up to 40 million human immune cells per week ...

Regulatory approval is only one marker of success for biotherapeutics. Biotherapeutics must also be commercially feasible. Too high a price tag can lead to limited availability to the targeted patient ...